TASIGNA: payments to doctors
Payments that named TASIGNA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 6,758
- Transactions
- 26,989
- Average per transaction
- $45
The per-transaction average — $45 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,758 providers the average total is $179, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $1,209,565 | 100.0% |
| Novartis Pharma AG | $57 | 0.0% |